CRISPR, crispr genome editing system

New CRISPR Genetic Tests is a SuperPowerful Tool to Diagnose Diseases Even in Remote and Desolate Regions // Investors See Economic Benefits of CRISPR

crispr_tests
Clinical pathology laboratory professionals have long been aware of the potential diagnostic properties related to CRISPR(Clustered Regularly Interspaced Short Palindromic Repeats) technology. Now, new tests using the gene-editing tool show that potential is being realized. One example involves using CRISPR to detect diseases in Nigeria, where a Lassa fever epidemic has already led to the death of 69 people this year alone. According the journal Nature, this diagnostic test “relies on CRISPR’s ability to hunt down genetic snippets—in this case, RNA from the Lassa virus—that it has been programmed to find. If the approach is successful, it could help to catch a wide range of viral infections early, so that treatments can be more effective and health workers can curb the spread of infection.” Researchers in Honduras...
Read More..
News No Comment

The Future of Medicine Land Within 5 – 10 Years, Crispr Inventor Says

rp_News-Doudna.jpg
A pioneer of the Crispr gene-editing technology that’s taken Wall Street by storm says the field is probably five to 10 years away from having an approved therapy for patients. Biochemist Jennifer Doudna, who runs the Doudna Lab at the University of California at Berkeley, says major questions remain about the safety and effectiveness of experimental therapies that aim to disrupt or repair defective genes. But she’s optimistic about their prospects. “Can we today edit the DNA in human cells? Yes. Can we do it accurately? Yes. That’s absolutely being done in many labs around the world now,” Doudna said in an interview on the sidelines of a gene-editing summit at the Cold Spring Harbor Laboratory in New York. “But the challenge is how...
Read More..
News No Comment

CRISPR Technology Market to Reach $10.55 Billion by 2027, Reports BIS Research

rp_test-tube-dna-gene.jpg
According to a new market intelligence report by BIS Research, titled “Global CRISPR Technology Market – Analysis and Forecast, 2018-2027“, the global CRISPR technology market is anticipated to grow to $10.55 billion by 2027. The global CRISPR technology market is projected to grow at a CAGR of 34.46% between the years 2018 and 2027, aided by the remarkable growth in the fields of therapeutic & drug discovery, biological research, and agricultural biotech.  Genetic diseases approximately constitute for 25% of global economic burden for disease. The rising prevalence of several genetic diseases has significantly elevated the requirement for improved gene targeting methods with greater efficiency. The recent advancements in sequencing and genomic technologies has paved pathway for the development of efficient genome editing...
Read More..
News No Comment

What is CRISPR gene editing, and how does it work?

You’ve probably read stories about new research using the gene editing technique CRISPR, also called CRISPR/Cas9. The scientific world is captivated by this revolutionary technology, since it is easier, cheaper and more efficient than previous strategies for modifying DNA. The term CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR associated protein 9. The names reflect important features identified during its discovery, but don’t tell us much about how it works, as they were coined before anyone understood what it was. What does CRISPR/Cas9 do? CRISPR/Cas9 is a system found in bacteria and involved in immune defence. Bacteria use CRISPR/Cas9 to cut up the DNA of invading bacterial viruses that might otherwise kill them. Today we’ve adapted this molecular machinery for an entirely different purpose – to change...
Read More..
News No Comment

CRISPR gene-editing tested in a person for the first time

crispr gene editing
A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique. On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu. Earlier clinical trials using cells edited with a different technique have excited clinicians. The introduction of CRISPR, which is simpler and more efficient than other techniques, will probably accelerate the race to get gene-edited cells into the clinic across the world, says Carl June, who specializes in immunotherapy at the University of Pennsylvania in Philadelphia and led one...
Read More..
News No Comment

‘C.R.I.S.P.R.': Jennifer Lopez Sets Futuristic Bio-Terror Drama at NBC

crispr_boom
NBC is reteaming with Jennifer Lopez for a futuristic procedural. The network has handed out a script order to drama C.R.I.S.P.R., which is being produced by the Shades of Blue star, The Hollywood Reporter has learned. C.R.I.S.P.R.— aka ” clustered regularly interspaced short palindromic repeats” — is a procedural thriller set five minutes into the future that explores the next generation of terror: DNA hacking. If the project moves forward, each episode will explore a bio-attack and crime — from a genetic assassination attempt on the president to the framing of an unborn child for murder. The show’s central character is a scientist with the CDC who is paired with an FBI agent. In the same vein of Castle, romance will...
Read More..
News No Comment

Cutting Out Cancer: CRISPR Gene Editing Could Make Cancer Mutations Inactive

crispr_core
A group of researchers from Dresden’s National Center for Tumor Disease (NCT), the Medical Faculty of the Technische Universität (TU) Dresden, and the German Consortium for Translational Cancer Research (DKTK), have found a way to use CRISPR-Cas9 to identify and cut out the particular cancer genes that advance mutations. “Mutations in cancer cells are identified at increasing speed through next generation sequencing, but we mostly do not know, which of these mutations are actually driving the disease and which ones are rather benign,” leading researcher Frank Buchholz said in a journal article. Of the more than 500,000 identified cancer mutations, the researchers were able to confirm that more than 80% can be cleaved using CRISPR-Cas9 scissors. DRIVER AND PASSENGER   National...
Read More..
News No Comment

CRISPR used to make a tumour shrink itself

crispr_boom
Scientists have used gene editing to reprogramme a signal that normally promotes tumour growth into one that shrinks it instead. In a study published in Nature Methods, a team from the First Affiliated Hospital of Shenzhen University, China, showed how they could stop the growth of cancer in cells by modifying part of the CRISPR–Cas9 system. When mice carrying these modified genes were tested, scientists found their tumours were far smaller than those seen in control animals. CRISPR-Cas9 is a gene editing platform that is currently being looked at as a means of providing treatments for diseases by targeting cells. Cas9 is an enzyme that cuts a double DNA strand at a point, while CRISPR is a chemical messenger. The...
Read More..
News No Comment

CRISPR: A Billion-Dollar Pie

CrisprMoney1
CRISPR sits in the middle of a costly patent brawl. That hasn’t stopped scientists and venture capitalists from betting on who will win. Business is moving fast with licenses being sold, awaiting the USPTO’s decision in November which may declare a winner on the patent. When it comes to pharmaceuticals, patents are licensed and traded in the amount of millions of dollars funneled through a 14 to 20-year timer. While the stakes are high, CRISPR/Cas9 is not the only gene editing technology out there. It was however, the first gene editing technology to be discovered in ancient bacteria, channeling new interest with the hope to discover an unclaimed and more effective gene editing technique. Who’s Who in the CRISPR Patent Brawl...
Read More..
News No Comment News No Comment